{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Embedded derivatives, Compounding effect, High risk",
    "classification": "complex",
    "supporting_data": "The product is a Leverage Shares 3x Palantir ETP Securities, which is a collateralised exchange traded security (ETP), not a UCITS ETF. It provides 3 times the daily performance of the underlying Palantir Technologies Inc. equity, implying significant leverage. The product uses synthetic replication via the iSTOXX Leveraged 3x PLTR Index, which tracks 3x daily performance through derivatives such as swaps. The ETP holds collateral assets and margin accounts to fund payment obligations, indicating embedded derivatives and counterparty risk. The product documentation explicitly warns about the compounding effect of daily leverage, which can cause returns to deviate significantly from 3x the underlying over longer holding periods, increasing complexity. The risk indicator is at the highest level (7/7), reflecting very high risk and complexity. The product is intended for sophisticated investors with very short holding horizons and the ability to monitor investments frequently. The KID includes a comprehension alert stating the product is not simple and may be difficult to understand. These featuresu2014significant leverage, synthetic replication with embedded derivatives, counterparty and collateral risk, and complex payoff structureu2014make the product complex under MiFID II rules and Article 57 criteria. The product is not UCITS compliant and is classified as an ETP, not an ETF. Therefore, it fails the baseline UCITS presumption of non-complexity and meets multiple complexity factors such as leverage, swaps, synthetic replication, and embedded derivatives. According to MiFID II and ESMA guidelines, such products require an appropriateness assessment before sale to retail investors due to their complexity and risk profile."
}